Success Metrics

Clinical Success Rate
76.5%

Based on 13 completed trials

Completion Rate
76%(13/17)
Active Trials
1(3%)
Results Posted
31%(4 trials)
Terminated
4(13%)

Phase Distribution

Ph early_phase_1
1
3%
Ph phase_2
5
16%
Ph phase_3
4
13%
Ph phase_4
13
41%
Ph not_applicable
2
6%
Ph phase_1
3
9%

Phase Distribution

4

Early Stage

5

Mid Stage

17

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
1(3.6%)
Phase 1Safety & dosage
3(10.7%)
Phase 2Efficacy & side effects
5(17.9%)
Phase 3Large-scale testing
4(14.3%)
Phase 4Post-market surveillance
13(46.4%)
N/ANon-phased studies
2(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

65.0%

13 of 20 finished

Non-Completion Rate

35.0%

7 ended early

Currently Active

1

trials recruiting

Total Trials

32

all time

Status Distribution
Active(3)
Completed(13)
Terminated(7)
Other(9)

Detailed Status

Completed13
unknown9
Terminated4
Withdrawn3
Not yet recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
1
Success Rate
76.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.6%)
Phase 13 (10.7%)
Phase 25 (17.9%)
Phase 34 (14.3%)
Phase 413 (46.4%)
N/A2 (7.1%)

Trials by Status

completed1341%
terminated413%
withdrawn39%
not_yet_recruiting26%
unknown928%
recruiting13%

Recent Activity

1 active trials
Showing 5 of 32
not_yet_recruitingphase_2

Mammogram Pretreatment With Ulipristal Acetate

NCT07434128
terminatedphase_4

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

NCT03537768
withdrawnphase_2

Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive

NCT03296098
completed

Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy

NCT05285605
not_yet_recruitingphase_3

Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception

NCT06727734
View all 32 trials

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT07434128Phase 2

Mammogram Pretreatment With Ulipristal Acetate

Not Yet Recruiting
NCT03537768Phase 4

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

Terminated
NCT03296098Phase 2

Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive

Withdrawn
NCT05285605

Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy

Completed
NCT06727734Phase 3

Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception

Not Yet Recruiting
NCT05674513Phase 4

Disparities in Emergency Contraceptive Metabolism Dictate Efficacy

Recruiting
NCT04004884

Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA)

Terminated
NCT01539720Not Applicable

Levonorgestrel Intrauterine System For Emergency Contraception

Completed
NCT02408770Phase 2

Breast Cancer - Anti-Progestin Prevention Study 1

Completed
NCT02587000Phase 2

Adenomyosis and Ulipristal Acetate

Completed
NCT04989400Phase 4

Use of Ulipristal Acetate in Induction of Second Trimester Missed Abortion

Completed
NCT02425878Phase 3

Ulipristal Acetate 10 mg and Asisted Reproduction

Terminated
NCT03802149Early Phase 1

Ulipristal Acetate for Cervical Preparation

Completed
NCT02825719Phase 4

Ulipristal Use in Chinese Population

Terminated
NCT02922127Phase 1

Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation

Completed
NCT02577601Phase 4

Impact of Combined Hormonal Contraceptives on UPA

Completed
NCT03349190

Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques

Completed
NCT03118297Phase 3

Intervention to End Recurrent Unscheduled Bleeding Trial

Completed
NCT02517463

Ulipristal Emergency Contraception Used Before or After Ovulation

Completed
NCT03186586Phase 4

Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
32